责任编辑：栎树 | 代码 | 名称 | | 涨幅% ↓ | 总市值 | 年初至今涨幅%。 | | --- | --- | --- | --- | --- | --- | | 688262 | 国芯科技 | 1 | 13.49 | 150亿 | 46.62 | | 688521 | 芯原股份 | 1 | 12.64 | 1136 Z | 57.65 | | 688048 | 长米华芯 | 1 | 9.90 | 258 乙 | 16.57 | | 688535 | 华海城科 | | 9.09 | 122亿 | 13.31 | | 300672 | 国科微 | + | 7.71 | 313亿 | 33.92 | | 688691 | 灿芯股份 | | 7.54 | 161亿 | 31.68 | | 600667 | 太极实业 | 1 | 7.44 | 208亿 | 24.97 | | 688498 | 源杰科技 | 4 | 7.31 | 663亿 | 20.19 | | 301095 | 广立微 | 第 | 7.28 | 155亿 | 7.71 | | 003043 | 华亚智能 | 长 | 6.96 | 70.5 ...

| 代码 | 名称 | | 涨幅% ↓ | 总市值 | 年初至今涨幅%。 | | --- | --- | --- | --- | --- | --- | | 688262 | 国芯科技 | 1 | 13.49 | 150亿 | 46.62 | | 688521 | 芯原股份 | 1 | 12.64 | 1136 Z | 57.65 | | 688048 | 长米华芯 | 1 | 9.90 | 258 乙 | 16.57 | | 688535 | 华海城科 | | 9.09 | 122亿 | 13.31 | | 300672 | 国科微 | + | 7.71 | 313亿 | 33.92 | | 688691 | 灿芯股份 | | 7.54 | 161亿 | 31.68 | | 600667 | 太极实业 | 1 | 7.44 | 208亿 | 24.97 | | 688498 | 源杰科技 | 4 | 7.31 | 663亿 | 20.19 | | 301095 | 广立微 | 兼 | 7.28 | 155亿 | 7.71 | | 003043 | 华亚智能 | 长 | 6.96 | 70.50亿 | 13. ...

格隆汇2月5日丨伟测科技(688372.SH)在投资者互动平台表示，公司和强力新材无业务合作。 ...

企查查APP显示，近日，成都伟测半导体科技有限公司成立，注册资本1亿元，经营范围包含：半导体 器件专用设备销售；半导体器件专用设备制造；集成电路芯片及产品制造；集成电路芯片及产品销售 等。企查查股权穿透显示，该公司由伟测科技全资持股。 ...

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Insights - The domestic model release period is intensifying, with significant models such as DeepSeek's open-source OCR2, Kimi's K2.5, Alibaba's Qwen3-Max-Thinking, and Baidu's Wenxin 5.0 being launched recently. ByteDance plans to release three new AI models in February, indicating a rapid acceleration in model commercialization [5] - Domestic cloud vendors are maintaining high capital expenditures, with ByteDance planning 160 billion yuan for 2026, up from approximately 150 billion yuan in 2025. Alibaba is also advancing a 3-year plan for 380 billion yuan in AI infrastructure [5] - The rapid iteration of domestic models is expected to significantly increase demand for inference-side computing power, with 2026 being a pivotal year for the deployment of domestic supernodes. Major companies like Huawei and Alibaba are launching new supernode solutions [5] - Investment suggestions highlight that the acceleration of domestic model iterations and improvements in inference-side performance will benefit the domestic computing power industry chain, with a focus on companies like Chipone Technology, Huafeng Technology, and Weicai Technology [5] Summary by Sections Recent Market Performance - The report notes a recent market performance with fluctuations, including a -13% change in one segment and a 67% increase in another [2] Key Company Ratings - Chipone Technology: Market cap of 109.3 billion yuan, with a rating of "Increase" [4] - Huafeng Technology: Market cap of 42.1 billion yuan, with a rating of "Increase" [4] - Weicai Technology: Market cap of 17.9 billion yuan, with no specific rating provided [4]

2月2日，伟测科技跌5.06%，截至发稿，报124.44元/股，成交1.94亿元，换手率1.02%，总市值185.48亿 元。 资料显示，上海伟测半导体科技股份有限公司位于上海市浦东新区东胜路38号D区1栋，成立日期2016 年5月6日，上市日期2022年10月26日，公司主营业务涉及晶圆测试、芯片成品测试以及与集成电路测试 相关的配套服务。主营业务收入构成为：晶圆测试55.40%，芯片成品测试40.09%，其他4.51%。 截至发稿，雷涛累计任职时间4年38天，现任基金资产总规模161.49亿元，任职期间最佳基金回报 320.08%， 任职期间最差基金回报-12.82%。 声明：市场有风险，投资需谨慎。 本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本 文出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@staff.sina.com.cn。 责任编辑：小浪快报 数据显示，德邦基金旗下1只基金位居伟测科技十大流通股东。德邦半导体产业混合发起式A （014319）三季度减持3.7万股，持有股数139.54万股，占流通股的比例为1.35%。根据测算，今日浮亏 ...

Group 1: Company Performance - Shengyi Technology (生益科技) expects a net profit attributable to shareholders of 3.25 to 3.45 billion yuan for 2025, representing a year-on-year increase of 87% to 98%. Shengyi Electronics (生益电子) anticipates a net profit of approximately 1.44 to 1.51 billion yuan, a year-on-year increase of 331.03% to 355.88% [4] - Wei Ce Technology (伟测科技) forecasts a net profit of around 300 million yuan for 2025, reflecting a year-on-year increase of approximately 133.96%. The growth is driven by the penetration of AI and automotive electronics, as well as the recovery in consumer electronics [4] - Jindan Technology (金丹科技) projects a net profit of 96 to 138 million yuan for 2025, indicating a significant year-on-year growth of 156% to 268%. The growth is attributed to the successful launch of a 50,000-ton lactic acid expansion project and a decrease in procurement costs [10] - Hengfeng Paper (恒丰纸业) anticipates a net profit of 178 to 215 million yuan for 2025, a year-on-year increase of 54% to 86%. The growth is primarily due to the successful launch of a new production line and breakthroughs in overseas markets [11] - Jieya Co. (洁雅股份) expects a net profit of 72 to 88 million yuan for 2025, representing a year-on-year increase of 270% to 352%. The growth is driven by increased orders from major international clients and an improved business structure [12] Group 2: Industry Trends - The European Automobile Manufacturers Association reported that pure electric vehicle sales in the EU surged by 51% year-on-year to 217,898 units in December 2025, surpassing gasoline vehicles for the first time. The market share reached 22.6% [7] - In December, China's newly installed photovoltaic capacity was 40 GW, a year-on-year decrease of 43% but an increase of 84% month-on-month. The cumulative installed capacity for the year reached 315 GW, a year-on-year increase of 14% [8] - The snack food sector, represented by Wancheng Group (万辰集团), is expected to see a net profit of 1.23 to 1.4 billion yuan for 2025, driven by the continuous growth of the bulk snack business and an increase in store numbers to approximately 19,000 [14]

◎记者 何昕怡 产销两旺 出海势头强劲 Wind数据显示，截至1月29日17时，近250家科创板公司"透底"2025年业绩相关情况，其中125家公司预 计实现盈利，占比约五成。从归母净利润增幅看，67家公司同比预计实现正增长（剔除扭亏），其中29 家公司业绩实现倍增。 从细分行业和属性来看，受益于市场需求复苏、主业提质增效、出海势头迅猛，半导体、生物医药、人 工智能等新兴产业景气度攀升，以亮眼业绩尽显科创风采。 产品销售放量、出海势头强劲等关键要素，勾勒出2025年科创板公司的发展轮廓。 "公司核心产品注射用紫杉醇聚合物胶束（紫杉醇胶束）于2025年正式纳入国家医保目录，在市场准入 与用药人数上大幅提高，带动公司全年营收与利润的显著增长。"上海谊众表示。据悉，该产品于2021 年成为国内首个获批上市的紫杉醇胶束制剂，主要针对晚期非小细胞肺癌适应症。 臻镭科技表示：报告期内，受国内特种行业周期影响，公司特种集成电路行业下游客户的产品需求有所 增加；同时公司积极把握卫星通信领域市场机遇，项目交付能力显著提升，整体推动销售收入实现高速 增长。 当前，国际化已成为上市公司高质量发展的主要路径之一。2025年，在海外市 ...

Earnings Forecasts - Shengyi Electronics expects a net profit of 1.431 billion to 1.513 billion yuan in 2025, an increase of 331.03% to 355.88% year-on-year [1] - Tigermed anticipates a net profit of 830 million to 1.23 billion yuan in 2025, representing a growth of 105% to 204% year-on-year [2] - Shunbo Alloy forecasts a net profit of 210 million to 270 million yuan in 2025, with an increase of 222.96% to 315.23% year-on-year [3] - Jinkong Electric expects a net profit of 155 million to 195 million yuan in 2025, reflecting a growth of 383.21% to 507.9% year-on-year [9] - Baiao Saitu anticipates a net profit of 162 million to 182 million yuan in 2025, with a year-on-year increase of 384.26% to 443.88% [18] - Panjiang Co. expects a net profit of 318 million to 380 million yuan in 2025, representing a growth of 205.30% to 264.83% year-on-year [38] Loss Forecasts - Liaoning Energy predicts a net loss of 273 million to 410 million yuan in 2025, compared to a profit of 202 million yuan in the previous year [5] - Anbotong anticipates a net loss of 114 million to 165 million yuan in 2025, with a revenue decrease of 19.65% to 27.25% [7] - Wantai Bio forecasts a net loss of 330 million to 410 million yuan in 2025, compared to a profit of 106 million yuan in the previous year [12] - Xingyun Co. expects a net loss of 155 million to 230 million yuan in 2025, compared to a loss of 82.44 million yuan in the previous year [20] - Huaxing Co. anticipates a net loss of 800 million to 1.2 billion yuan in 2025, with a reduction in loss compared to 1.67 billion yuan in the previous year [46] New Product Approvals - Hengrui Medicine received acceptance for a new indication application for its innovative drug, combining Carrelizumab and Apatinib for treating unresectable liver cancer [4] - Tianen Kang's subsidiary received a drug registration acceptance notice for Lidocaine and Prilocaine aerosol [31] - Lisheng Pharmaceutical announced that its Aminophylline tablets passed the consistency evaluation for generic drugs [40] Share Buyback Plans - Hengyuan Coal Power plans to repurchase shares with a total amount not less than 200 million yuan and not exceeding 250 million yuan [13] Contract Wins - China Communication Signal Co. won contracts totaling approximately 5.26 billion yuan for 21 important projects in the railway and urban rail transit markets [37]

格隆汇1月29日｜有投资者在互动平台向伟测科技提问：据报道，得益于DRAM与NAND Flash大厂冲刺 出货，力成、华东、南茂等存储封测厂订单涌进，产能利用率近乎满载，近期陆续调升封测价格，调幅 上看三成，且"后续不排除启动第二波涨价"。请问公司是否也相应的上调了封测价格？ 伟测科技回复称，公司是独立第三方集成电路测试企业，目前测试价格总体较为稳定。 ...